Daiwa Securities Group
COGT icon

Daiwa Securities Group’s Cogent Biosciences COGT Stock Holding History

Daiwa Securities Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-416
Closed -$15K – 1241
2025
Q4 		$15K Hold
416
– – ﹤0.01% 1167
2025
Q3 		$6K Hold
416
– – ﹤0.01% 1187
2025
Q2 		$3K Hold
416
– – ﹤0.01% 1188
2025
Q1 		$2K Hold
416
– – ﹤0.01% 1178
2024
Q4 		$3K Hold
416
– – ﹤0.01% 1189
2024
Q3 		$4K Buy
416
+135
+48% +$1.31K ﹤0.01% 1179
2024
Q2 		$2K Hold
281
– – ﹤0.01% 1246
2024
Q1 		$2K Hold
281
– – ﹤0.01% 1264
2023
Q4 		$2K Hold
281
– – ﹤0.01% 1268
2023
Q3 		$3K Hold
281
– – ﹤0.01% 1193
2023
Q2 		$3K Hold
281
– – ﹤0.01% 1217
2023
Q1 		$3K Hold
281
– – ﹤0.01% 1180
2022
Q4 		$3K Buy
281
+165
+142% +$2.04K ﹤0.01% 1189
2022
Q3 		$2K Hold
116
– – ﹤0.01% 1219
2022
Q2 		$1K Hold
116
– – ﹤0.01% 1282
2022
Q1 		$1K Hold
116
– – ﹤0.01% 1300
2021
Q4 		$1K Buy
+116
New +$1.01K ﹤0.01% 1330
2019
Q4 		– Sell
-49
Closed – – 1209
2019
Q3 		$0 Hold
49
– – ﹤0.01% 1183
2019
Q2 		$1K Hold
49
– – ﹤0.01% 1172
2019
Q1 		$1K Buy
+49
New +$838 ﹤0.01% 1159

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Daiwa Securities Group's COGT Position: Q1 2026 in Review

Daiwa Securities Group sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 416 shares — an estimated $15K sold.

Daiwa Securities Group first reported a position in COGT in Q1 2019 and held it in 20 quarters. The position peaked at $15K in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Daiwa Securities Group reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 416 Cogent Biosciences shares in Q1 2026, an estimated $15K.
  • Daiwa Securities Group first reported a position in Cogent Biosciences in Q1 2019 and held it in 20 quarters.
  • Daiwa Securities Group's Cogent Biosciences position peaked at $15K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.